...
tsha-img

Taysha Gene Therapies Inc, Common Stock

TSHA

NSQ

$1.83

-$0.02

(-1.08%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$379.14M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
2.9365
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.54M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.41
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.19 L
$4.32 H
$1.83

About Taysha Gene Therapies Inc, Common Stock

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTSHASectorS&P500
1-Week Return-8.96%-0.94%-2.6%
1-Month Return-36.68%-5.08%-1.08%
3-Month Return-9.85%-10.62%3.45%
6-Month Return-31.2%-6.18%8.57%
1-Year Return8.28%1.98%24.3%
3-Year Return-85.65%-0.93%25.58%
5-Year Return-92.39%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---2.50M15.45M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":16.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue-9.00K492.00K2.49M1.37M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.36,"profit":true},{"date":"2021-12-31","value":19.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.13,"profit":true}]
Gross Profit-(9.00K)(492.00K)15.00K15.45M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.06,"profit":false},{"date":"2021-12-31","value":-3.18,"profit":false},{"date":"2022-12-31","value":0.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin-(Infinity%)(Infinity%)0.60%100.00%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":0.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses1.11M43.00M173.27M128.53M87.89M[{"date":"2019-12-31","value":0.64,"profit":true},{"date":"2020-12-31","value":24.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.18,"profit":true},{"date":"2023-12-31","value":50.73,"profit":true}]
Operating Income(1.11M)(43.00M)(173.27M)(162.45M)(72.44M)[{"date":"2019-12-31","value":-111500000,"profit":false},{"date":"2020-12-31","value":-4300200000,"profit":false},{"date":"2021-12-31","value":-17326700000,"profit":false},{"date":"2022-12-31","value":-16244700000,"profit":false},{"date":"2023-12-31","value":-7243900000,"profit":false}]
Total Non-Operating Income/Expense-(16.99M)(2.51M)(7.12M)(42.87M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1698800000,"profit":false},{"date":"2021-12-31","value":-251200000,"profit":false},{"date":"2022-12-31","value":-711600000,"profit":false},{"date":"2023-12-31","value":-4286700000,"profit":false}]
Pre-Tax Income(1.11M)(60.01M)(174.52M)(166.01M)(111.57M)[{"date":"2019-12-31","value":-111500000,"profit":false},{"date":"2020-12-31","value":-6001100000,"profit":false},{"date":"2021-12-31","value":-17452300000,"profit":false},{"date":"2022-12-31","value":-16601400000,"profit":false},{"date":"2023-12-31","value":-11156600000,"profit":false}]
Income Taxes(4.46M)(17.01M)936.00K3.57M1.20M[{"date":"2019-12-31","value":-125.04,"profit":false},{"date":"2020-12-31","value":-476.9,"profit":false},{"date":"2021-12-31","value":26.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":33.73,"profit":true}]
Income After Taxes-(43.00M)(175.46M)(169.58M)(112.77M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4300000000,"profit":false},{"date":"2021-12-31","value":-17545900000,"profit":false},{"date":"2022-12-31","value":-16958100000,"profit":false},{"date":"2023-12-31","value":-11276910500,"profit":false}]
Income From Continuous Operations-(60.01M)(174.52M)(166.01M)(214.38M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-6001100000,"profit":false},{"date":"2021-12-31","value":-17452300000,"profit":false},{"date":"2022-12-31","value":-16601400000,"profit":false},{"date":"2023-12-31","value":-21438500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(1.11M)(43.00M)(175.46M)(169.58M)(111.57M)[{"date":"2019-12-31","value":-111500000,"profit":false},{"date":"2020-12-31","value":-4300000000,"profit":false},{"date":"2021-12-31","value":-17545900000,"profit":false},{"date":"2022-12-31","value":-16958100000,"profit":false},{"date":"2023-12-31","value":-11156600000,"profit":false}]
EPS (Diluted)-(3.60)(4.63)(3.78)0.13[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2769.23,"profit":false},{"date":"2021-12-31","value":-3561.54,"profit":false},{"date":"2022-12-31","value":-2907.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TSHA
Cash Ratio 5.38
Current Ratio 5.51

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TSHA
ROA (LTM) -27.42%
ROE (LTM) -114.77%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TSHA
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TSHA
Trailing PE 2.94
Forward PE NM
P/S (TTM) 38.24
P/B 4.27
Price/FCF NM
EV/R 28.64
EV/Ebitda NM

FAQs

What is Taysha Gene Therapies Inc share price today?

Taysha Gene Therapies Inc (TSHA) share price today is $1.83

Can Indians buy Taysha Gene Therapies Inc shares?

Yes, Indians can buy shares of Taysha Gene Therapies Inc (TSHA) on Vested. To buy Taysha Gene Therapies Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TSHA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Taysha Gene Therapies Inc be purchased?

Yes, you can purchase fractional shares of Taysha Gene Therapies Inc (TSHA) via the Vested app. You can start investing in Taysha Gene Therapies Inc (TSHA) with a minimum investment of $1.

How to invest in Taysha Gene Therapies Inc shares from India?

You can invest in shares of Taysha Gene Therapies Inc (TSHA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TSHA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Taysha Gene Therapies Inc shares
What is Taysha Gene Therapies Inc 52-week high and low stock price?

The 52-week high price of Taysha Gene Therapies Inc (TSHA) is $4.32. The 52-week low price of Taysha Gene Therapies Inc (TSHA) is $1.19.

What is Taysha Gene Therapies Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Taysha Gene Therapies Inc (TSHA) is 2.9365

What is Taysha Gene Therapies Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Taysha Gene Therapies Inc (TSHA) is 4.27

What is Taysha Gene Therapies Inc dividend yield?

The dividend yield of Taysha Gene Therapies Inc (TSHA) is 0.00%

What is the Market Cap of Taysha Gene Therapies Inc?

The market capitalization of Taysha Gene Therapies Inc (TSHA) is $379.14M

What is Taysha Gene Therapies Inc’s stock symbol?

The stock symbol (or ticker) of Taysha Gene Therapies Inc is TSHA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top